Krajina: Nórsko
Jazyk: nórčina
Zdroj: Statens legemiddelverk
Gallium (67Ga) sitrat
Mallinckrodt Medical B.V.
V09HX01
Gallium (67Ga) citrate
37 MBq/ ml
Injeksjonsvæske, oppløsning
Hetteglass i blyemballasje 5.5 ml
C
Markedsført
1999-11-01
1 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Gallium (Ga67) Citrate Injection (Mallinckrodt Medical catalogue number: DRN 3103) 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Composition per ml at activity reference date and time 67 Ga as gallium citrate 37 MBq The qualitative composition is in conformity with the monograph 555 of the European Pharmacopoeia. Gallium ( 67 Ga) is a radionuclide (Atomic number 31; atomic weight 67) and has a physical half-life of 3.3 days (78.3 hours). It decays to stable zinc by electron capture emitting gamma energies of 93 keV (38%), 185 keV (21%) and 300 keV (16.8%). A small but clinically insignificant amount of 66 Ga is present as a natural contaminant (see dosimetry). For excipients, see section 6.1 3 PHARMACEUTICAL FORM Solution for injection 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS This product is for diagnostic use only 4.1.1 Non-specific tumour imaging and/or localising agent Gallium may be used in conjunction with other imaging modalities in the diagnosis, staging and subsequent management of malignant lymphomas such as Hodgkin and non-Hodgkin lymphoma. It may also be of subsequent use in establishing response to chemotherapy. 67 Ga imaging can be helpful in the diagnosis of bronchial neoplasm by establishing the extent of mediastinal spread. It has also been used to ascertain the degree of dissemination of other malignant primaries with varying reliability. 4.1.2 Localisation of inflammatory lesions Gallium may be used in establishing a diagnosis in specific inflammatory disorders, particularly those affecting the lung such as sarcoidosis and opportunistic infections due to Pneumocystis carinii. In sarcoidosis and interstitial lung disease uptake is influenced by disease activity. Gallium ( 67 Ga) may be useful in characterising and/or localising extrapulmonary inflammatory lesions e.g. tuberculous lymphadenopathy or in the investigation of fever of unknown origin. It provides only non-specific evidence of inflammatory sites within the body Prečítajte si celý dokument